Skip to main content
. 2017 Feb 21;8(13):21472–21482. doi: 10.18632/oncotarget.15592

Table 2. Paclitaxel-derived toxicities in the two study arms.

Arm A (paclitaxel plus nintedanib) Arm B (paclitaxel) P value
Grade 1 or 2
Neuropathy (average, range) 0.6 (0–3) 1.1 (0–4) 0.023
Myalgia (average, range) 0.3 (0–3) 0.35 (0–3) 0.689
Fatigue (average, range) 1.4 (0–4) 1.6 (0–4) 0.38
Arm A (paclitaxel plus nintedanib) Arm B (paclitaxel) P value
Grade 3 or 4
Neuropathy (average, range) 0 (0–0) 0 (0–0) N/A
Myalgia (average, range) 0 (0–0) 0 (0–0) N/A
Fatigue (average, range) 0 (0–0) 0 (0–0) N/A